Similarly, Colicchia et al.’s study, a gene expression analysis of 498 human neuroblastoma samples, found PARP-1 expression to be higher at advanced stages of neuroblastoma and MYCN-amplified tumours [15]. This evidence concerns the gene MYCN and neuroblastoma.